Delivery Order SPE2DR25D3301-SPE2DR26F21ET
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,891.92 to AmerisourceBergen Drug Corp on January 9, 2026, for PHESGO 600-600 MG pharmaceutical product in 20,000 unit quantities of 10ML vials. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 2, 2026. AmerisourceBergen Drug Corp, a subsidiary...
- The Defense Logistics Agency awarded a delivery order valued at $5,630.64 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials) with a firm fixed price structure. This non-competitive delivery order, issued on January 20, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 10, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order valued at $17,256.90 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 10ML units (20,000 units total). This is a firm fixed-price delivery order with an ultimate completion date of December 29, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of PHESGO 600-600 mg medication in 20,000 units of 10ml vials. This competitively awarded, non-set-aside contract carries a ceiling value of $17,256.90 with a firm fixed price structure and an ultimate completion date of January 13, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $11,504.60 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 20,000 units of 10ML vials, with performance concluding by December 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $11,261.28 firm fixed-price delivery order by the Defense Logistics Agency on January 5, 2026, for PHESGO 600-600 mg pharmaceutical product (20,000 units of 10ml vials). This is a non-set-aside contract with an ultimate completion date of January 27, 2026. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- This delivery order, valued at $16,375.17, was awarded on August 21, 2025, to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 mg in 10 mL unit dosages totaling 20,000 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain. The award was made on a competitive basis without any set-aside designation. AmerisourceBergen's place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $11,504.60 to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG pharmaceutical product, consisting of 20,000 units of 10ML vials. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by December 9, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21ETDelivery Order
On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,630.64 to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials). This firm fixed-price, competitively awarded contract carries an ultimate completion date of February 13, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates substantial capability in fulfilling Defense Logistics Agency pharmaceutical requirements through open competition. The company's extensive portfolio of federal contract awards encompasses delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This particular delivery order represents a routine component of the company's ongoing pharmaceutical supply operations under the DLA Troop Support Medical contract structure, which strategically positions multiple contractors to serve the Department of Defense Health Agency, U.S. Coast Guard, and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 1/22/26 |